11 Apr. 2019

BIOVERSYS' LATEST PRESS RELEASE DISCUSSING BIOVERSYS' TUBERCULOSIS PROJECT

Press Release for the article on part of the discoveries in BioVersys' Tuberculosis project which was published in one of the top 5 scientific journal...


11 Apr. 2019

BIG BUCKS AGAINST RESISTANT BUGS - 10TH BERLIN CONFERENCE ON LIFE SCIENCES

Since the withdrawal of Big Pharma in the late '80s, the antibiotic research market has dried up. Article here


11 Apr. 2019

BIOVERSYS AG AND APTUIT ANNOUNCE COLLABORATION

BioVersys AG and Aptuit have announced the start of their joint collaboration to identify novel approaches to treat serious infections from gram-negat...


11 Apr. 2019

WHO STRESSES URGENT NEED FOR R&D FOR DRUG-RESISTANT TB ALONGSIDE NEWLY-PRIORITIZED ANTIBIOTIC-RESISTANT PATHOGENS

WHO reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB)....